Biogen Denies Patient Drug

Discussion in 'BiogenIdec' started by anonymous, Apr 2, 2021 at 4:24 AM.

Tags: Add Tags

  1. anonymous

    anonymous Guest

    Maybe management will offer them covid instead.
     
  2. anonymous

    anonymous Guest

    Maybe they’ll get it from one the reps they’re forcing back in the field by doubling the call expectations?
     
  3. anonymous

    anonymous Guest


    Thats really not funny when someone is dying because they don't have access to a drug that exists.
     
  4. anonymous

    anonymous Guest

  5. anonymous

    anonymous Guest

    This is prime example of the article author using hyperbole and NOT telling the complete story.

    while I’m NOT a trumper, one of his hallmark narratives about ‘fake news’ does sometime hold water. The ‘news’ is no longer about providing the news; it’s about how they can spin a story so it fits what their audience wants to hear. That on turn strengthens ratings (or click through) and leads to better ad revenue.

    It’s a business of subtle lies and only partial coverage of the story.

    journalists are heading the same direction as the cable company, airlines and cell phone providers....lower and lower in public perception and rankings.
     
  6. anonymous

    anonymous Guest

    Another Biogen drug with an attempt at carefully designing a trial to engineer an outcome

    Management is not too confident in this drug outside of the perfectly manicured trial design and outside of the small handful of sites selected. Giving it to someone outside of the setup, with media attention to if it works/doesn’t work, is too big of a risk.

    BTW, did you see the protest outside the Cambridge office? There were actually a few Biogen employees there. Look at the pictures.
     
  7. anonymous

    anonymous Guest

    The nejm data didn't look very good with timelines that seem to keep extending. Wish something worked significantly on als (even some
    forms) but didn't look like this was it.